Company Profile
Materialise Stock Price, News & Analysis
- Ticker:
- MTLS
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- Belgium
Stock performance
6.75 USD (-0.59%)
Close
Last updated: August 6, 2026
401M USD
Market cap
Why the stock is moving
As of Aug 6, 2026, MTLS closed down 0.59% at $6.75. No new same-company headline was identified in the current news window.
Company overview
Additive-Manufacturing Technology
Materialise is a global 3D-printing company providing software, production services and medical applications. Its technology supports the design and manufacture of complex parts from digital models.
Medical Solutions
The medical segment develops patient-specific surgical planning tools, anatomical models, implants and other 3D-printed devices used by clinicians and medical-device companies.
Manufacturing Software
Materialise sells software used to prepare, manage and optimize additive-manufacturing workflows across industrial and healthcare customers.
Production Services
The company also manufactures prototypes and end-use parts for customers that require additive-manufacturing capacity without operating their own production infrastructure.
Future catalysts
Materialise's catalysts are 3D-printing adoption, orthopedic software, and medical-application demand. The company benefits when clinical and industrial demand both stay healthy.
Recent news
- 01
MATERIALISE AANDELENINKOOPPROGRAMMA
Source: Materialise
- 02
MATERIALISE SHARE-BUY BACK PROGRAM
Source: Materialise
- 03
- 04
Materialise houdt jaarlijkse aandeelhoudersvergadering op 16 juni 2026
Source: Materialise
- 05
Materialise to Hold Annual Shareholders’ Meeting on June 16, 2026
Source: Materialise
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Materialise (MTLS)?
Materialise (MTLS) most recently closed at 6.75 USD, a -0.59% move versus the previous session.
What is the market cap of Materialise (MTLS)?
Materialise currently has a market capitalization of 401M USD on BioPharmSignal.
What does Materialise do?
Additive-Manufacturing Technology Materialise is a global 3D-printing company providing software, production services and medical applications. Its technology supports the design and manufacture of complex parts from digital models. Medical Solutions The medical segment develops patient-specific surgical planning tools, anatomical models, implants and other...
On which exchange is MTLS stock listed?
Materialise (MTLS) is associated with NASDAQ, Belgium, Biopharma.
What is Additive-Manufacturing?
Additive-Manufacturing Technology Materialise is a global 3D-printing company providing software, production services and medical applications.
Which conditions is Materialise targeting with Additive-Manufacturing?
Additive-Manufacturing Technology Materialise is a global 3D-printing company providing software, production services and medical applications. Its technology supports the design and manufacture of complex parts from digital models. Medical Solutions The medical segment develops patient-specific surgical planning tools, anatomical models, implants and other...
How does Materialise describe recent progress with Additive-Manufacturing?
Materialise's catalysts are 3D-printing adoption, orthopedic software, and medical-application demand. The company benefits when clinical and industrial demand both stay healthy.
What is Technology?
Additive-Manufacturing Technology Materialise is a global 3D-printing company providing software, production services and medical applications.